Finally, real visibility into your investigator grants
Investigator costs are large, complex, and notoriously difficult to track. Harder still, the data needed to do it accurately is scattered across disconnected systems. Auxilius integrates disparate data sources, giving you a unified, real-time view of your investigator grants – with insights to drive better decisions.
Real-time insights that drive better decisions about investigator grants
End-to-end investigator transparency.
From the moment site budgets are negotiated through end-of-study reconciliation, Auxilius provides a single source of truth to manage highly variable investigator grants spend.
Planning and forecasting built to manage site spend.
Plan and forecast site spend using your own protocols, contracted costs, and site enrollment data, so you always know where your site budgets stand.
Rich insights that compound with your programs.
Every study adds to your unified data asset, giving you cross-portfolio perspective and actionable data to manage current studies and plan for future ones.
Everything you need to manage the full lifecycle of your investigator grants
Capabilities purpose-built to forecast, track, and reconcile investigator grants – all in one place.
Automated integration of CTA, EDC, and payments data
Auxilius maps and integrates your site contracts, EDC data, and payments data into a single data model – no homegrown trackers, no manual data entry, no wrangling ClinOps for trial updates.
Investigator grant cost tracking
Get a complete and accurate estimate of investigator costs for your clinical accrual – grounded in your own clinical data rather than a high-level CRO estimate.
Investigator dashboard
Get a portfolio-level view of investigator spend across all your studies – total costs, enrolled patients, and trends by site, region, and invoiceable category, all in one place.
Investigator transactions and cost detail
Every patient visit, site invoiceable, and patient invoiceable in your study, paired with its contracted cost in real time – giving you transaction-level detail across every site, region, and patient group in your study.
Investigator payments reconciliation
Auxilius validates every site payment against your own clinical data, transaction by transaction – catching overbillings, duplicate charges, and unbilled costs across every site, region, and study in your portfolio.
Investigator grant forecasting
Forecast investigator costs from your own enrollment data, site contracts, and discontinuation trends – patient by patient, site by site, giving you an independent view of your most unpredictable cost category.
White glove support from a world-class team
Work with a team that knows your site contracts as well as you do
When you buy Auxilius you buy more than software. Every Auxilius customer receives dedicated support from our 20-person operations team that includes clinical data specialists and clinical trial veterans that are committed to your success – all out of the box.
- Dedicated clinical data lead to oversee your investigator model configuration
- Clinical data analysts to support clinical data mapping, ingestion, and QA
- Unlimited help desk support and access to Auxilius training library with 90+ user guides
Governance
Frequently Asked Questions
Auxilius Investigator Intelligence takes your own CTAs, EDC data, and protocol design to translate actual visits and procedures into real-time investigator expense - transaction by transaction. That same model powers investigator spend forecasting and investigator reconciliation to catch site over-,under-, and duplicate billing.
Auxilius receives enrollment and visit information from the study’s Electronic Data Capture (EDC) system. This data is used to update investigator cost estimates and project future patient visits.
Auxilius uses data from executed Clinical Trial Agreements (CTAs) at each individual site to determine visit and invoiceable costs. These contracts are typically provided after execution, and the system extracts detailed visit and invoiceable budget information to build the costs into the clinical model. CTAs are used as key inputs for forecasting, expense estimation, and reconciliation against payments reports.
When EDC data lags, Auxilius can predicts which patient visits should have occurred based on protocol schedules – so your cost estimates reflect what has most likely happened, not what’s been entered.
Auxilius estimates the total Investigator Expense by converting the EDC data into the $ per transaction using the cost data from the CTAs (visits and invoiceables). Auxilius compares the Investigator Expense to the payment details provided by the payments provider to reconcile the EDC-driven expense in Auxilius against the payments transaction in the Investigator Reconciliation page.
Yes! Auxilius's pro-forma payments service generates site-level invoices directly from your investigator transaction data so sponsors can pay sites directly with your own payments provider. That way, sites can be paid accurately and on time without waiting on your CRO.
Discover a new approach to clinical trial financial management
